AIDS TREATMENT NEWS Issue #237, December 22, 1995
Mark Mascolini
As a result of a recent "recompetition" for funding, clinical trials at seven of the 35 current sites will be phased out over the next year, and two new sites will be added to the surviving sites. NIH will continue to fund clinical trials at defunded sites only if they require the data which those patients would provide; otherwise, patients will be referred to other clinical research centers.
More drastic ACTG cuts were first discussed, including elimination of major research sites at Harvard and New York University, although it has been denied that plans were changed in order to save these sites. There is concern that other AIDS research may be cut to pay for centers which were saved. The NIH refuses to speculate whether the budget for the ACTG, or the entire NIH clinical research budget, will likely increase or decrease until Congress and the Administration agree on their total budget, which at press time has again been stalled in partisan negotiations.
The seven existing sites which will be phased out over the next year are:
Connecticut: Yale University
District of Columbia: Georgetown University
New York: Albany Medical College
New York: Albert Einstein College of Medicine
New York: Columbia Presbyterian Medical Center
New York: SUNY/Brooklyn
Tennessee: Meharry Medical College (Nashville)
951222
ATN23708
Copyright © 1995 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .